Capsugel has acquired the FlexTab technology, a dosage form developed by GlaxoSmithKline. The technology uses injection molding processes to produce unique capsule-shaped dosage forms that offer a new platform for formulating a wide range of new products. The FlexTab technology allows for a variety of fill materials, including powders, pellets, liquids, micro-tablets and tablets, and can deliver separate liquid and powder API’s in one dose, allowing for new product designs and customizatio...